Hee-jung Lee

Nung-dong, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Recombinant AcHERV-baculovirus vaccine elicits robust immune responses against human norovirus.

Recombinant AcHERV-baculovirus vaccine elicits robust immune responses against human norovirus.

Journal: Vaccine
Published: January 05, 2026

Current Perspectives and Future Directions in the Immunogenicity Landscape of Norovirus Vaccines.

Current Perspectives and Future Directions in the Immunogenicity Landscape of Norovirus Vaccines.

Journal: Journal of microbiology and biotechnology
Published: September 02, 2025

Delivery of SARS-CoV-2 spike and membrane genes in a single Baculoviral vector enhance the immune breadth against SARS-CoV-2 variants of concern.

Delivery of SARS-CoV-2 spike and membrane genes in a single Baculoviral vector enhance the immune breadth against SARS-CoV-2 variants of concern.

Journal: Vaccine
Published: June 18, 2024

Generation of rescued Japanese encephalitis virus genotype 1 from infectious full-size clone using reverse genetics.

Generation of rescued Japanese encephalitis virus genotype 1 from infectious full-size clone using reverse genetics.

Journal: Heliyon
Published: June 05, 2024

Baculovirus Vector-Based Varicella-Zoster Virus Vaccine as a Promising Alternative with Enhanced Safety and Therapeutic Functions.

Baculovirus Vector-Based Varicella-Zoster Virus Vaccine as a Promising Alternative with Enhanced Safety and Therapeutic Functions.

Journal: Vaccines
Published: February 16, 2024

Timing of maternal vaccination against COVID-19 for effective protection of neonates: cohort study.

Timing of maternal vaccination against COVID-19 for effective protection of neonates: cohort study.

Journal: Frontiers in immunology
Published: December 21, 2023

Comparative Biodistribution Study of Baculoviral and Adenoviral Vector Vaccines against SARS-CoV-2.

Comparative Biodistribution Study of Baculoviral and Adenoviral Vector Vaccines against SARS-CoV-2.

Journal: Journal of microbiology and biotechnology
Published: August 23, 2023

The N-terminal peptide of the main protease of SARS-CoV-2, targeting dimer interface, inhibits its proteolytic activity.

The N-terminal peptide of the main protease of SARS-CoV-2, targeting dimer interface, inhibits its proteolytic activity.

Journal: BMB reports
Published: August 21, 2023

Antiviral Activity Against SARS-CoV-2 Variants Using in Silico and in Vitro Approaches.

Antiviral Activity Against SARS-CoV-2 Variants Using in Silico and in Vitro Approaches.

Journal: Journal of microbiology (Seoul, Korea)
Published: March 23, 2023

Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice.

Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice.

Journal: Vaccine
Published: October 31, 2022

Comparison of Six Serological Immunoassays for the Detection of SARS-CoV-2 Neutralizing Antibody Levels in the Vaccinated Population.

Comparison of Six Serological Immunoassays for the Detection of SARS-CoV-2 Neutralizing Antibody Levels in the Vaccinated Population.

Journal: Viruses
Published: March 15, 2022

The Safe Baculovirus-Based PrM/E DNA Vaccine Protected Fetuses Against Zika Virus in A129 Mice.

The Safe Baculovirus-Based PrM/E DNA Vaccine Protected Fetuses Against Zika Virus in A129 Mice.

Journal: Vaccines
Published: March 30, 2021
Showing 1-12 of 30

Last Updated: 09/26/2026